Recommendations on Interferon Gamma Release Assaysfor the Diagnosis of Latent Tuberculosis Infection-2010 Update: An Advisory Committee Statement (ACS) Canadian Tuberculosis Committee (CTC)*.
作者信息
Kunimoto Dennis, Gardam Drs Michael, Kitai Ian, Menzies Dick, Morshed Muhammad, Pai Madhukar, Ward Heather, Webster Duncan, Wobeser Wendy
出版信息
Can Commun Dis Rep. 2010 Jun 1;36(ACS-5):1-22. doi: 10.14745/ccdr.v36i00a05.
Abstract
摘要
相似文献
1
Recommendations on Interferon Gamma Release Assaysfor the Diagnosis of Latent Tuberculosis Infection-2010 Update: An Advisory Committee Statement (ACS) Canadian Tuberculosis Committee (CTC)*.《2010年更新版：γ-干扰素释放试验用于潜伏性结核感染诊断的建议：咨询委员会声明（ACS）》加拿大结核病委员会（CTC）*
Can Commun Dis Rep. 2010 Jun 1;36(ACS-5):1-22. doi: 10.14745/ccdr.v36i00a05.
2
Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).关于潜伏性结核感染的干扰素γ释放试验的更新建议。一份咨询委员会声明（ACS）。
Can Commun Dis Rep. 2008 Oct;34(ACS-6):1-13.
3
Interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).用于潜伏性结核感染的干扰素γ释放试验。一份咨询委员会声明（ACS）。
Can Commun Dis Rep. 2007 Nov 1;33(ACS-10):1-18.
4
Recommendations on the use of live, attenuated influenza vaccine (FluMist): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).关于使用减毒活流感疫苗（FluMist）的建议：2011 - 2012年季节性流感疫苗补充声明 免疫国家咨询委员会（NACI）咨询委员会声明（ACS）
Can Commun Dis Rep. 2011 Nov 30;37(ACS-7):1-77. doi: 10.14745/ccdr.v37i00a07.
5
Recommendations on the use of MF59-Adjuvanted Trivalent Influenza Vaccine (Fluad): Supplemental Statement of Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).关于使用MF59佐剂三价流感疫苗（Fluad）的建议：2011 - 2012年季节性流感疫苗补充声明 免疫咨询委员会声明（ACS） 国家免疫咨询委员会（NACI）
Can Commun Dis Rep. 2011 Oct 21;37(ACS-6):1-68. doi: 10.14745/ccdr.v37i00a06.
6
Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).儿童期结合肺炎球菌疫苗使用情况更新：咨询委员会声明（ACS） 国家免疫咨询委员会（NACI）
Can Commun Dis Rep. 2010 Nov 23;36(ACS-12):1-21. doi: 10.14745/ccdr.v36i00a12.
7
Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) .人乳头瘤病毒（HPV）疫苗最新情况：一份咨询委员会声明（ACS） 国家免疫咨询委员会（NACI）
Can Commun Dis Rep. 2012 Jan 2;38(ACS-1):1-62. doi: 10.14745/ccdr.v38i00a01.
8
Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).水痘疫苗两剂接种建议：一份咨询委员会声明（ACS） 国家免疫咨询委员会（NACI）
Can Commun Dis Rep. 2010 Sep 20;36(ACS-8):1-26. doi: 10.14745/ccdr.v36i00a08.
9
Updated Statement on the use of Rotavirus Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).轮状病毒疫苗使用的最新声明：咨询委员会声明（ACS） 国家免疫咨询委员会（NACI）
Can Commun Dis Rep. 2010 Jul 16;36(ACS-4):1-37. doi: 10.14745/ccdr.v36i00a04.
10
Updated Recommendations for the Use of Varicella and MMR Vaccines In HIV-Infected Individuals: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).HIV感染个体使用水痘疫苗和麻疹-腮腺炎-风疹疫苗的更新建议：一份咨询委员会声明（ACS） 国家免疫咨询委员会（NACI）
Can Commun Dis Rep. 2010 Sep 16;36(ACS-7):1-19. doi: 10.14745/ccdr.v36i00a07.
引用本文的文献
1
Prevalence of latent tuberculosis infection among coal workers' pneumoconiosis patients in China: a cross-sectional study.中国煤工尘肺患者潜伏性结核感染的流行率：一项横断面研究。
BMC Public Health. 2018 Apr 11;18(1):473. doi: 10.1186/s12889-018-5373-1.
2
Latent tuberculosis infection among a large cohort of medical students at a teaching hospital in Italy.意大利一家教学医院大批医学生中的潜伏性结核感染情况。
Biomed Res Int. 2015;2015:746895. doi: 10.1155/2015/746895. Epub 2015 Feb 1.
3
Quantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values.QuantiFERON Gold-in-tube assay 用于 HIV 感染儿童的 TB 筛查：定量值的影响。
BMC Infect Dis. 2014 Sep 23;14:516. doi: 10.1186/1471-2334-14-516.
4
Added value of QuantiFERON TB-gold in-tube for detecting latent tuberculosis infection among persons living with HIV/AIDS.管内QuantiFERON TB-金标检测法在检测HIV/AIDS感染者中潜伏性结核感染的附加价值。
Biomed Res Int. 2014;2014:294963. doi: 10.1155/2014/294963. Epub 2014 May 29.
5
Application and interpretation of an interferon-gamma release assay: Results of an audit in a Canadian centre.干扰素-γ 释放试验的应用和解读：加拿大中心审计结果。
Can J Infect Dis Med Microbiol. 2012 Winter;23(4):183-6. doi: 10.1155/2012/838465.
6
Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.在格鲁吉亚，艾滋病毒感染者中，干扰素-γ释放试验与结核菌素皮肤试验之间的一致性较差。
BMC Infect Dis. 2013 Nov 1;13:513. doi: 10.1186/1471-2334-13-513.
7
Latent tuberculosis infection and associated risk factors among undergraduate healthcare students in Italy: a cross-sectional study.意大利本科医学生中的潜伏性结核感染及相关危险因素：一项横断面研究。
BMC Infect Dis. 2013 Sep 23;13:443. doi: 10.1186/1471-2334-13-443.
8
Immunosuppression Adversely Affects TST but Not IGRAs in Patients with Psoriasis or Inflammatory Musculoskeletal Diseases.免疫抑制对银屑病或炎性肌肉骨骼疾病患者的结核菌素皮肤试验（TST）有不利影响，但对干扰素-γ释放试验（IGRAs）无影响。
Int J Rheumatol. 2012;2012:381929. doi: 10.1155/2012/381929. Epub 2012 May 16.
9
Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States.干扰素-γ释放试验在医护人员筛查项目中的应用：来自美国一家三级保健中心的经验。
Can Respir J. 2012 Mar-Apr;19(2):84-8. doi: 10.1155/2012/576324.
10
Interferon-gamma release assays for screening of health care workers in low tuberculosis incidence settings: dynamic patterns and interpretational challenges.用于在低结核病发病率地区筛查医护人员的干扰素-γ释放试验：动态模式及解读挑战
Can Respir J. 2012 Mar-Apr;19(2):81-3. doi: 10.1155/2012/420392.
本文引用的文献
1
Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.一种基于干扰素的新型血液检测——全血γ-干扰素释放试验（QuantiFERON-TB Gold）在筛查结核病接触者中的成本效益。
Int J Tuberc Lung Dis. 2008 Dec;12(12):1414-24.
2
Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).关于潜伏性结核感染的干扰素γ释放试验的更新建议。一份咨询委员会声明（ACS）。
Can Commun Dis Rep. 2008 Oct;34(ACS-6):1-13.
3
Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan.日本结核菌素γ干扰素释放试验用于结核病接触者筛查的成本效益分析
Mol Diagn Ther. 2008;12(4):235-51. doi: 10.1007/BF03256289.
4
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.系统评价：基于T细胞的检测方法用于潜伏性结核感染的诊断：最新进展
Ann Intern Med. 2008 Aug 5;149(3):177-84. doi: 10.7326/0003-4819-149-3-200808050-00241. Epub 2008 Jun 30.
5
Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.全血γ-干扰素检测对近期结核分枝杆菌感染后活动性结核病发生的预测价值。
Am J Respir Crit Care Med. 2008 May 15;177(10):1164-70. doi: 10.1164/rccm.200711-1613OC. Epub 2008 Feb 14.
6
Interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).用于潜伏性结核感染的干扰素γ释放试验。一份咨询委员会声明（ACS）。
Can Commun Dis Rep. 2007 Nov 1;33(ACS-10):1-18.
7
Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?结核病的系列检测：我们能理解T细胞检测结果的转化和逆转吗？
PLoS Med. 2007 Jun;4(6):e208. doi: 10.1371/journal.pmed.0040208.
8
T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward.用于诊断潜伏性结核感染的T细胞检测：推动研究议程向前发展。
Lancet Infect Dis. 2007 Jun;7(6):428-38. doi: 10.1016/S1473-3099(07)70086-5.
9
Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.用于潜伏性结核治疗的γ-干扰素释放试验检测的成本效益
Eur Respir J. 2007 Aug;30(2):321-32. doi: 10.1183/09031936.00145906. Epub 2007 May 15.
10
Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.荟萃分析：潜伏性结核感染诊断的新检测方法：不确定性领域及研究建议
Ann Intern Med. 2007 Mar 6;146(5):340-54. doi: 10.7326/0003-4819-146-5-200703060-00006.
Zotero 插件